Latest Market News

Alpha HPA Limited reports a surge in semiconductor sector demand driven by AI infrastructure expansion, with significant upgrades in Letters of Intent from key Japanese customers and ongoing capacity expansion.

FINEOS Corporation reports robust FY25 financial performance, driven by subscription revenue growth and embedded AI innovations, setting a confident outlook through FY27.

Emu NL has announced a pro-rata non-renounceable rights issue aiming to raise approximately $3.67 million, offering new shares with free attaching options to eligible shareholders. The capital raise will primarily fund exploration activities at its Queensland projects and strengthen working capital.

Synertec Corporation Limited has reported a robust first half of FY26, with a 20% increase in group revenue and a significant $135 million engineering tender pipeline, underscoring its growing footprint in energy technology and engineering services.

Rumble Resources has reported promising metallurgical testwork from its Western Queen Gold and Tungsten Project, confirming the potential for high-grade tungsten concentrate production alongside gold. The company is advancing a scoping study to fast-track tungsten mining and processing amid soaring global prices.

EML Payments has received Supreme Court approval for its $37.36 million shareholder class action settlement, enabling the company to refocus on its strategic growth plans.

Vertex Minerals has arranged a A$9 million convertible loan facility to support underground gold production at its Reward Gold Mine, with conversion into shares and options pending shareholder approval.

Brazilian Rare Earths Limited has secured a key Trial Mining Licence for its Monte Alto project, marking a significant step toward commercial rare earths production in Brazil.

HomeCo Daily Needs REIT has announced its ordinary quarterly distribution of AUD 0.0215 per unit for the period ending 31 March 2026, alongside details of its Dividend Reinvestment Plan.

4DMedical’s advanced lung imaging technology CT:VQ™ has been deployed at the Mayo Clinic, marking the sixth top US academic medical centre to adopt the system within seven months of FDA clearance.

Clarity Pharmaceuticals has signed a significant manufacturing supply agreement with Theragenics to produce copper-64, a key isotope for its upcoming prostate cancer diagnostic, Cu-SAR-bisPSMA. This deal strengthens Clarity’s US supply network ahead of anticipated FDA approval and commercial launch.

Nickel Industries has secured a significant increase in its 2026 ore sales license and finalized a long-term supply agreement for its Excelsior Nickel Cobalt project, enhancing production certainty and sustainability.